Episode 7: Envirosuite, ooh Media and Rocket Lab

Shares have grown 4-fold already in 2019

At bottom the ability to buy securities – particularly common stocks – successfully is the ability to look ahead accurately. Looking backward, however carefully, will not suffice, and may do more harm than good.” — Benjamin Graham The financial statements can tell you a great deal about a company, and any serious investor ignores them at their own peril. Revenue, margins, […]

This week, we revisit Wisetech (ASX:WTC) following its cash grab; should investors participate in the capital raise? Also, we run the ruler over water specialist Fluence (ASX:FLC) and we ask whether fan favourite ProMedicus (ASX:PME) is now too expensive. Plus, we talk about the pros and cons of using leverage, why position sizing is so important to your returns and […]

The concept of ‘value’ is core to investing. At one level, it’s a relatively straightforward idea, and one we intuitively understand. As investors, we are, essentially, trying to buy assets for less than what they are “really” worth. For us, the value is captured when the wider market recognises and corrects the mispricing. But there’s also value in something that is (somehow) perfectly […]

Following a big week of half-yearly reports on the ASX, the guys cover six of their favourite stocks — and all in under 40 minutes! Stocks covered: Appen (ASX:APX), MNF Group (ASX:MNF), Nanosonics (ASX:NAN), A2 Milk (ASX:A2M), Webjet (ASX:WEB) & ProMedicus (ASX:PME).

This week, we discuss Paragon’s (ASX:PGC) profit downgrade, Nearmap’s (ASX:NEA) stellar performance and why Kip McGrath (ASX:KME) is Claude’s second largest position. Plus, Matt takes us through how he likes to prepare for earnings season, and why it matters.

what does this mean for shareholders?

A lot of investors seem to be pivoting their investment strategies in light of the coronavirus crisis. Mine, for better or worse, remains essentially unchanged: Seek to acquire a range of quality companies with a view to holding them for many years.  Aim to hold between 10-15 companies that do not have highly correlated risks. A quality company is one […]